Friday, 16 October 2026European Markets

Northern Drilling Soars 30% As Trading Day Closes

Loading stream...

(VIANEWS) - Wednesday mid-day trading saw shares of NORTHERN DRILLING (NODL.OL) experience an unexpected 30.77% surge, rising to close at kr5.78 following three consecutive sessions of losses. Meanwhile, the Oslo Bors Benchmark Index_GI had also seen gains, rising 0.9% after two negative sessions; investors welcomed this positive development - particularly with NODL's last close being at 4.42 which is 87% below its 52-week high of 35.90!

About NORTHERN DRILLING

Northern Drilling Ltd. is an offshore drilling contractor in the oil and gas industry, specialising in acquiring, operating, and drilling ultra-deep water environments. Established in 2017 with its base located in Hamilton Bermuda, the company provides expertise and innovation tailored to meet industry demands.

Yearly Analysis

Based on the available information, it appears that NORTHERN DRILLING's stock has experienced a considerable decrease in value since reaching its 52-week high of kr21.00 one year ago. This indicates an extensive drop-off. However, investors must remember that past performance does not guarantee future returns. Before making investment decisions based on past results alone, investors should carefully assess factors like financial health of a company's financials, industry trends and overall market conditions before making their decisions. If you are considering investing in Northern Drilling, conducting further research may help determine whether its stock is currently undervalued or overvalued. This may involve reviewing financial statements, researching industry trends and seeking expert opinions. Overall, it's essential that any investment decision be approached with care and that all relevant factors be carefully taken into consideration before reaching a conclusion.

Technical Analysis

Northern Drilling stock has experienced a downward trend recently, falling below both its 50-day and 200-day moving averages in terms of value. Yet its volume has seen an incredible surge of over 4880% compared to average, suggesting increased investor interest. Northern Drilling's current intraday variation average has been consistently negative over the last week, month, and quarter; its highest amplitude of average volatility being 0.72% for last week; 2.133% for month; and 3.27% for quarter. Stochastic oscillator data suggests that Northern Drilling stock may currently be overbought (>=80), suggesting it could be due for a correction and therefore present investors with an opportunity to enter at lower price points. Overall, NORTHERN DRILLING's stock seems volatile and uncertain at present, experiencing a downward trend and being considered overbought. However, an increase in volume may signal potential buying opportunities in the near future; investors should therefore exercise caution and conduct further research prior to making investment decisions.

Equity Analysis

Northern Drilling currently boasts an EPS figure of kr-0.96, suggesting that they have generated negative earnings per share over the last year and may not yet be profitable - something which should concern any prospective investors. Additionally, the company's return on equity (ROE) for the twelve trailing months stands at negative 4.22% - an indication that their investors have not seen returns on their equity investment from this venture. A negative ROE should serve as a warning sign to investors searching for companies with higher ROE figures as this indicates effective use of equity investments by companies to produce profits for shareholders. Overall, Northern Drilling appears to present an unfavorable investment outlook based on these two financial indicators. Potential investors should carefully review both of them along with any additional relevant information before making their final investment decisions.

More news about NORTHERN DRILLING (NODL.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com